Study of Anemia in Chronic Kidney Disease (CKD) Among High-Risk Hypertensive and Diabetic Patients in Pakistan

Completed

• Conditions: Anemia, Diabetes, Kidney Disease, Chronic, Hypertension

• Registration Number: NCT02444845
• Lead Sponsor: Hoffmann-La Roche

Brief Summary

The purpose of this study is to evaluate the prevalence of CKD-related anemia at an early stage through screening of high-risk patients in Pakistan at the level of physicians, cardiologists, and diabetologists. The information gathered may serve as a foundation in formulating national guidelines for better early diagnosis and management of patients with CKD.

Detailed Description

Not available

Study Timeline

• Study Start: 2011-05
• Primary Completion: 2012-08
• Study Completion: 2012-08
• Study First Submitted: 2015-05-12
• Study First Submitted QC: 2015-05-14
• Study First Posted: 2015-05-15
• Status Verified: 2018-03
• Last Update Submitted: 2018-03-19
• Last Update Posted: 2018-03-20

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 246

Inclusion Criteria

• Age greater than or equal to 40 years
• Known hypertension and/or diabetes for at least 3 years
• Positive dipstick test result for proteinuria

Read More

Exclusion Criteria

• Known CKD
• Receiving erythropoietin
• Blood transfusion within 8 weeks
• History of acute or chronic bleeding, hemolysis, or hemoglobinopathy

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Number of patients with anemia secondary to CKD	Up to 12 months

Secondary Outcome Measures

Name	Time	Method
Use of treatment modalities for the management of anemia secondary to CKD	Up to 12 months